
Founded in 1995, ACTRIMS brings together leaders from the US and Canada committed to advancing treatment and research in MS and other demyelinating diseases. The organization focuses on fostering collaboration, education and knowledge dissemination to drive innovation in the field.
The ACTRIMS Forum 2025 promises a rich program featuring insights into aging and MS progression, cross-disorder and neuroanatomical connections, and the latest developments in brain repair and protection. Attendees can expect a unique, CE-accredited single-track format with scientific and clinical presentations, over 500 research posters and plenty of networking opportunities in a dynamic Industry Hub.
Highlights include the prestigious Kenneth P Johnson Memorial Lecture, delivered by Dr Jack Antel of McGill University, a distinguished clinical neurologist and MS researcher. The Forum will also host the National MS Society’s Barancik Prize ceremony, celebrating groundbreaking innovation in MS research.
Supporting the next generation of MS researchers is a cornerstone of ACTRIMS’ mission. The Forum’s opening session will feature young investigator presentations, while educational grants and the pre-conference Neurology Resident Summit will provide opportunities for trainees to explore career paths in neuroimmunology.
For more information, visit the event website at forum.actrims.org or follow the conversation on Twitter and LinkedIn using #ACTRIMSForum.
Disclosures: This short article was created by touchNEUROLOGY. No fees or funding were associated with the publication of this article.
***
SIGN UP to touchNEUROLOGY!
Join our global community today for access to thousands of peer-reviewed articles, expert insights, and learn-on-the-go education across 150+ specialties, plus concise email updates and newsletters so you never miss out.
Click here to REGISTER NOW >>>
***
This Content is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.